In particular, cytotoxic CD8+ T cells, which can specifically recognize and kill tumor cells, are associated with a good clinical outcome in different cancer types [5] and have a pivotal role in anti-PD1 immunotherapy [1]. The gene discussed is CD8A; the disease is neoplasm.